6/12/2025
New Phase 2 Clinical Trial: TEV-CeD2 Study
New Phase 2 Clinical Trial: TEV-CeD2 Study
Continue ReadingFeatured News
Tag: celiac alerts
3/13/2025
Enroll in a Celiac Disease Research Study Today
The ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingRecent Posts
- Celiac Disease Takes Center Stage at FNCE® 2025
- Science Meets Advocacy: A New Era for Celiac Disease Progress
- World Osteoporosis Day: Celiac Disease and Bone Health
- Understanding Sudden Antibody Changes in Children at Risk for Celiac Disease
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation
Dear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...